study on the Key molecular mechanisms of obstructive sleep apnea related hypertension

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400084603

Enrollment

Unknown

Registered

2024-05-21

Start date

2024-06-01

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea related hypertension

Interventions

OSA+hypertension:None

hypertension:None

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) Age =18 years, education =7 years; (2) No hearing comprehension disorder, can tolerate polysomnosis monitoring and other tests; (3) To participate in this study voluntarily, patients and their families sign informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) PSG was used to exclude other sleep disorders such as central apnea, narcolepsy, restless leg syndrome, etc.; (2) Secondary hypertension, combined with severe liver and kidney insufficiency and other serious physical diseases; (3) Use sedative and antipsychotic drugs within 4 weeks; (4) Can not cooperate with the completion of polysomnia monitoring and other tests

Design outcomes

Primary

Measure	Time frame
Protein;metabolite;	—

Secondary

Measure	Time frame
sleep;	—

Countries

China

Contacts

Public ContactJuan Liu

Army Medical Center

liujuan961@163.com+86 139 8373 3548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026